MedPath

Feasibility and Acceptability of a Single Session of Imagery Rescripting in a Community Sample of Adults

Early Phase 1
Completed
Conditions
Feasibility Studies
Acceptability
Depressive Symptoms
Disordered Eating Behaviors
Registration Number
NCT06610318
Lead Sponsor
University of Oregon
Brief Summary

Negative experiences related to eating and appearance (NEREAs), such as critical commentary from parents about food, are common. They are also associated with depression and disordered eating, predictors of early mortality. Imagery rescripting (IR) is a therapeutic process during which individuals are guided through recalling distressing memories, like NEREAs, and generating ideas for bringing support into these memories. Single sessions of IR demonstrate promise in shifting the primary negative consequences of NEREAs in clinical samples of women. The current study examined the feasibility and acceptability of a remote-delivered, single session of IR in a community sample of men and women with NEREAs.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
27
Inclusion Criteria
  1. ≥18 years old
  2. endorse a history of at least one negative experience related to eating and/or appearance
Exclusion Criteria
  1. endorsed a current major medical condition;
  2. met criteria for a full threshold psychiatric disorder (of moderate intensity when severity ratings are necessary, such as for substance use disorders and binge eating disorder);
  3. were at high risk for suicide;
  4. endorsed current or recent pregnancy or anticipated becoming pregnant within the next year;
  5. were taking medication known to affect eating, weight and/or chronic disease risk;
  6. were participating in eating, weight, or diabetes programming;
  7. experienced weight loss > 10% in the past six months; and/or
  8. could not complete study procedures in English.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
data collection completenessbaseline, intervention, 1-month, and 3-month

% of missing data collected at all study visits

intervention acceptabilitythese data will be collected during the 1-month follow-up visit

captured via self-report survey items created by the researchers; participants were asked questions such as the extent to which they liked engaging in the intervention; response options are on a Likert-type scale ranging from strongly agree to strongly disagree; average scores at the item level will be generated by condition

safetythese data will be collected during and between all study visits, from baseline though the 3-month follow-up visit

frequency of adverse events

retentionfrom baseline through the 3-month follow-up visit

the % of participants retained at each visit relative to baseline (i.e., percentage of total enrolled who attended the intervention visit, the 1-month follow-up visit, and the 3-month follow-up visit)

enrollmentonce, at baseline, over the duration of recruitment to obtain the sample size of interest

the total number of participants enrolled in the study and a demographic description of these participants, including their sex, gender, race, ethnicity, age and body mass index

fidelityduring the intervention session only

the % of intervention curriculum the interventionists cover during their intervention session as rated by research staff using a curriculum checklist

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Oregon

🇺🇸

Eugene, Oregon, United States

University of Oregon
🇺🇸Eugene, Oregon, United States
© Copyright 2025. All Rights Reserved by MedPath